首页> 外文期刊>European journal of pharmaceutical sciences >The use of sodium carboxymethylcellulose in the preparation of spray-dried proteins for pulmonary drug delivery.
【24h】

The use of sodium carboxymethylcellulose in the preparation of spray-dried proteins for pulmonary drug delivery.

机译:羧甲基纤维素钠在制备用于肺部药物递送的喷雾干燥蛋白中的用途。

获取原文
获取原文并翻译 | 示例
           

摘要

The use of sodium carboxymethylcellulose (NaCMC) as a spray-drying excipient in the preparation of inhalable formulations of proteins was investigated, using alkaline phosphatase as a model functional protein. Two spray-dried powders were investigated: a control powder comprising 100% (w/w) alkaline phosphatase and a test powder comprising 67% (w/w) NaCMC and 33% (w/w) alkaline phosphatase. Following physicochemical characterisation, the powders were prepared as both dry powder inhaler (DPI) and pressurised metered dose inhaler (pMDI) formulations. The aerosolisation performance of the formulations was assessed using a Multi-Stage Liquid Impinger, both immediately after preparation and over a 16-week storage period. Formulating the control powder as a DPI resulted in a poor fine particle fraction (FPF: 10%), whereas the FPF of the NaCMC-modified DPI formulation was significantly greater (47%). When the powders were formulated as pMDI systems, the control and NaCMC-modified powders demonstrated FPFs of 52% and 55%, respectively. Following storage, reduced FPF was observed for all formulations except the NaCMC-modified pMDI system; the performance of this formulation following storage was statistically equivalent to that immediately following preparation. Co-spray-drying proteins and peptides with NaCMC may therefore offer an alternative method for the preparation of stable and respirable pMDI formulations for pulmonary delivery.
机译:使用碱性磷酸酶作为模型功能蛋白,研究了羧甲基纤维素钠(NaCMC)作为喷雾干燥赋形剂在制备蛋白质可吸入制剂中的用途。研究了两种喷雾干燥的粉末:包含100%(w / w)碱性磷酸酶的对照粉末和包含67%(w / w)NaCMC和33%(w / w)碱性磷酸酶的测试粉。根据理化特性,将粉末制成干粉吸入器(DPI)和加压计量吸入器(pMDI)制剂。在制备后立即和在16周的储存期内,均使用Multi-Stage液体撞击器评估了制剂的雾化性能。将对照粉末配制为DPI会导致较差的细颗粒分数(FPF:10%),而NaCMC改性的DPI制剂的FPF明显更高(47%)。当将粉末配制为pMDI系统时,对照粉末和NaCMC改性粉末的FPF分别为52%和55%。储存后,除NaCMC修饰的pMDI系统外,所有制剂的FPF均降低。该制剂在储存后的性能在统计学上等同于制备后立即的性能。因此,与NaCMC共同喷雾干燥的蛋白质和多肽可能为制备稳定且可呼吸的pMDI制剂提供另一种方法,用于肺部递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号